RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–CDW (Nasdaq: CDW), today announced the addition of two new strategy and marketing…
“NEXT” reflects Bermuda’s momentum in attracting institutional-grade digital asset companies seeking a credible regulatory jurisdiction…
MONTRÉAL, Québec, June 10, 2022 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”)…
LEXINGTON, Mass., June 10, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in…
SAN DIEGO, June 10, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
FREMONT, CA, June 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
81% of evaluable patients achieved an objective response Deep responses: 64% are CR/CRi, of which…
Ongoing experiments will evaluate the functionality and efficacy of GTB-7550 in vivo Future studies will…
Multiplex deletion of myeloid antigens CD33 and CLL-1 in human hematopoietic stem cells demonstrates potential…
TORONTO, June 10, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Preclinical data demonstrate VIP152 as the most selective CDK9 inhibitor compared with other CDK9 inhibitors,…
— Results, which were previously pre-printed in bioRxiv, show Gritstone’s second-generation self-amplifying mRNA (samRNA) vaccine…
NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or…
First RSV vaccine candidate to show statistically significant and clinically meaningful efficacy in adults aged…
PALO ALTO, Calif., June 10, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio)…
PHILADELPHIA, June 10, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the…
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF MAY 2022 VANCOUVER, BC, CANADA, June 10,…
– Achieved up to 6.3% hemoglobin F (HbF) induction in initial subjects in first cohort;…
WATERTOWN, Mass., June 10, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…